These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 30570457

  • 21. Focal segmental glomerulosclerosis and kidney transplantation.
    Gheith O, Hassan R.
    Iran J Kidney Dis; 2013 Jul; 7(4):257-64. PubMed ID: 23880801
    [Abstract] [Full Text] [Related]

  • 22. Focal segmental glomerulosclerosis in pediatric kidney transplantation: 30 years' experience.
    Cleper R, Krause I, Bar Nathan N, Mor M, Dagan A, Weissman I, Frishberg Y, Rachamimov R, Mor E, Davidovits M.
    Clin Transplant; 2016 Oct; 30(10):1324-1331. PubMed ID: 27490751
    [Abstract] [Full Text] [Related]

  • 23. Rituximab for Recurrence of Primary Focal Segmental Glomerulosclerosis After Kidney Transplantation: Clinical Outcomes.
    Garrouste C, Canaud G, Büchler M, Rivalan J, Colosio C, Martinez F, Aniort J, Dudreuilh C, Pereira B, Caillard S, Philipponnet C, Anglicheau D, Heng AE.
    Transplantation; 2017 Mar; 101(3):649-656. PubMed ID: 27043407
    [Abstract] [Full Text] [Related]

  • 24. Recurrent focal glomerulosclerosis: natural history and response to therapy.
    Artero M, Biava C, Amend W, Tomlanovich S, Vincenti F.
    Am J Med; 1992 Apr; 92(4):375-83. PubMed ID: 1558084
    [Abstract] [Full Text] [Related]

  • 25. Immunoadsorption for Recurrent Primary Focal Segmental Glomerulosclerosis on Kidney Allografts: A Single-Center Experience and Literature Review.
    Naciri Bennani H, Bonzi JY, Noble J, Terrec F, Motte L, Imerzoukene F, Bugnazet M, Giovannini D, Janbon B, Malvezzi P, Rostaing L, Jouve T.
    Blood Purif; 2020 Apr; 49(3):322-333. PubMed ID: 31913143
    [Abstract] [Full Text] [Related]

  • 26. Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient.
    Cho JH, Lee JH, Park GY, Lim JH, Kim JS, Kang YJ, Kwon O, Choi JY, Park SH, Kim YL, Kim HK, Huh S, Kim CD.
    Ren Fail; 2014 May; 36(4):623-6. PubMed ID: 24502587
    [Abstract] [Full Text] [Related]

  • 27. Management of recurrent focal segmental glomerulosclerosis (FSGS) post renal transplantation.
    Al Shamsi HR, Shaheen I, Aziz D.
    Transplant Rev (Orlando); 2022 Jan; 36(1):100675. PubMed ID: 34952298
    [Abstract] [Full Text] [Related]

  • 28. Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children.
    Fine RN.
    Pediatr Nephrol; 2007 Apr; 22(4):496-502. PubMed ID: 17186280
    [Abstract] [Full Text] [Related]

  • 29. Rescue with obinutuzumab and daratumumab as combined B cell/plasma cell targeting approach in severe posttransplant focal segmental glomerulosclerosis recurrence.
    Randone P, Sanna E, Dolla C, Gallo E, Mingozzi S, Tarragoni R, Torazza MC, Niarchos A, Mella A, Manzione AM, Barreca A, Deambrosis I, Giraudi R, Biancone L.
    Am J Transplant; 2024 Oct; 24(10):1896-1900. PubMed ID: 39029875
    [Abstract] [Full Text] [Related]

  • 30. Renal allograft survival in transplant recipients with focal segmental glomerulosclerosis.
    Cibrik DM, Kaplan B, Campbell DA, Meier-Kriesche HU.
    Am J Transplant; 2003 Jan; 3(1):64-7. PubMed ID: 12492712
    [Abstract] [Full Text] [Related]

  • 31. Combined rituximab and plasmapheresis or plasma exchange for focal segmental glomerulosclerosis in adult kidney transplant recipients: a meta-analysis.
    Hansrivijit P, Ghahramani N.
    Int Urol Nephrol; 2020 Jul; 52(7):1377-1387. PubMed ID: 32306197
    [Abstract] [Full Text] [Related]

  • 32. Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients.
    Pardon A, Audard V, Caillard S, Moulin B, Desvaux D, Bentaarit B, Remy P, Sahali D, Roudot-Thoraval F, Lang P, Grimbert P.
    Nephrol Dial Transplant; 2006 Apr; 21(4):1053-9. PubMed ID: 16364987
    [Abstract] [Full Text] [Related]

  • 33. Long-Term Outcomes of Kidney Transplant Recipients With Primary Idiopathic Focal Segmental Glomerulosclerosis.
    Staeck O, Halleck F, Budde K, Khadzhynov D.
    Transplant Proc; 2017 Dec; 49(10):2256-2259. PubMed ID: 29198656
    [Abstract] [Full Text] [Related]

  • 34. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M, Ampuero J, Anaya F.
    Transplant Proc; 2009 Dec; 41(6):2406-8. PubMed ID: 19715934
    [Abstract] [Full Text] [Related]

  • 35. Therapeutic Approach for Recurrent Focal Segmental Glomerulosclerosis in Pediatric Renal Transplant Recipients: A Single-Center Experience.
    Torres DD, Fontò G, Guastamacchia L, Santangelo L, Carbone V, Piscopo G, Spadaccino F, Ranieri E, Netti GS, Giordano M.
    Blood Purif; 2022 Dec; 51(10):847-856. PubMed ID: 35093944
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and Safety of Bleselumab in Preventing the Recurrence of Primary Focal Segmental Glomerulosclerosis in Kidney Transplant Recipients: A Phase 2a, Randomized, Multicenter Study.
    Shoji J, Goggins WC, Wellen JR, Cunningham PN, Johnston O, Chang SS, Solez K, Santos V, Larson TJ, Takeuchi M, Wang X.
    Transplantation; 2024 Aug 01; 108(8):1782-1792. PubMed ID: 39042770
    [Abstract] [Full Text] [Related]

  • 37. Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience.
    Lionaki S, Vlachopanos G, Georgalis A, Liapis G, Skalioti C, Zavos G, Boletis JN.
    Ren Fail; 2015 Jun 01; 37(5):777-83. PubMed ID: 25715638
    [Abstract] [Full Text] [Related]

  • 38. Re-transplantation in pediatric patients with failure of primary transplant due to recurrent focal segmental glomerulosclerosis: A pediatric nephrology research consortium study.
    Maniar A, Hooper DK, Sethna CB, Singer P, Traum A, Benoit E, Kotzen E, Verghese P, Garro R, Kamel M, Ranch D, Shih W, Jain NG, Al-Akash S.
    Pediatr Transplant; 2021 Nov 01; 25(7):e14085. PubMed ID: 34247442
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of intravenous combined immunosuppression with plasmapheresis in adult patients with refractory primary focal segmental glomerulosclerosis.
    Dirim AB, Demir E, Guller N, Safak S, Artan AS, Oto OA, Ozluk Y, Ozturk S, Yazici H, Kalayoglu-Besisik S, Turkmen A.
    J Clin Apher; 2022 Aug 01; 37(4):376-387. PubMed ID: 35535432
    [Abstract] [Full Text] [Related]

  • 40. Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function.
    Sener A, Bella AJ, Nguan C, Luke PP, House AA.
    Clin Transplant; 2009 Aug 01; 23(1):96-100. PubMed ID: 19200221
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.